Analysts Viewpoint
Zentalis Pharmaceuticals Inc [ZNTL] Shares Fall Approximately -54.79% Over the Year
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Zentalis Pharmaceuticals Inc’s recent filing unveils that its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zentalis Pharmaceuticals
Zentalis Pharmaceuticals Inc’s filing revealed that its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr 30
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Zentalis Pharmaceuticals Inc’s recently made public that its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zentalis Pharmaceuticals
In a filing, Zentalis Pharmaceuticals Inc revealed its Director Myers Scott Dunseth acquired Company’s shares for reported $29373.0 on Apr